Chromosome Translocation-Mediated Conversion of a Tumor Suppressor Gene into a Dominant Oncogene: Fusion of EWS1 to WT1 in Desmoplastic Small Round Cell Tumors

  • F. J. RauscherIII
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 220)


The preceding articles in this volume have provided a unique overview of genetic and biochemical mechanisms which underlie oncogenic conversion of transcription factor function. As is evident, many of the models have derived from the study of pediatric and adult leukemias. These studies have provided a paradigm for the emerging analyses of chromosomal translocations involving transcription factors in solid tumors. This is exemplified by the manuscript of Barr who examines the PAX3-FKHR fusion transcription factor whose mechanism likely involves increased activation of normal PAX3 target genes. A similar but probably not identical mechanistic theme is echoed by the EWS and TLS fusions described by Ron and May. Like PAX3-FKHR, the EWS/TLS fusions confer a novel activation domain to an otherwise unaltered DNA binding domain, thereby creating a dominant oncogene. Most remarkable is the diversity of DNA-binding domain types which are involved in EWS/TLS fusions and, concomitantly, the diversity of the disease processes initiated. This article will expand on this theme by describing a new member of the EWS/TLS family of oncogenes, namely EWS-WT1, which occurs in the solid tumor desmoplastic small round cell sarcoma (DSRCT). The EWS-WT1 fusion is unique in that its DNA binding domain is derived from the Wilms’ tumor-1 (WT1) tumor suppressor protein. This is one of the first examples of chromosomal-translocation-mediated fusion of a proto-oncogene (EWS) and a tumor suppressor gene (WT1) which creates a dominant oncogene. In order to understand the context of these findings, we will first provide brief reviews of the biology and genetics of WT1, EWS, and DSRCT.


Myxoid Liposarcoma Metanephric Mesenchyme Extraskeletal Myxoid Chondrosarcoma Zinc Finger Region Early Growth Response Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Beckwith JB, Kiviat NB, Bonadio JF (1990) Nephrogenic rests, nebroblastomatosis and the pathogenesis of Wilms’ tumor. Pediatr Pathol 10: 1 – 36PubMedCrossRefGoogle Scholar
  2. Biegel JA, Conard K, Brooks JJ (1993) Translocation (11;22)(pl3;ql2): Primary change in intra-ab-dominal desmoplastic small round cell tumor. Genes Chromosome Cancer 7: 119 – 121CrossRefGoogle Scholar
  3. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 60: 509 – 520PubMedCrossRefGoogle Scholar
  4. Cook DM, Hinkes MT, Bernfield M, Rauscher III FJ (1996) Transcriptional activation of the Syndecan-1 promoter by the Wilms’ tumor protein WT1. Oncogene 13: 1789 – 1799PubMedGoogle Scholar
  5. Coppes MJ, Campbell CE, Williams BRG (1993) The role of WT1 in Wilms’ tumorigenesis. FASEB J 7: 886 – 895PubMedGoogle Scholar
  6. Crozat A, Aman P, Mandahl N, Ron D (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363: 640 – 644PubMedCrossRefGoogle Scholar
  7. de Alava E, Ladanyi M, Rosai J, Gerald WL (1995) Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. 147: 1584 – 1590Google Scholar
  8. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359: 162 – 165PubMedCrossRefGoogle Scholar
  9. Delattre O, Zucman J, Melot T, Garau XS, Zucker J-M, Lenoir GM, Ambros PF, Sheer D, TurcCarel C, Triche TJ, Aurias A, Thomas G (1994) The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331: 294 – 299PubMedCrossRefGoogle Scholar
  10. Dey SR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ III, Kim S-J (1994) Repression of the transforming growth factor-beta 1 gene by the Wilms’ tumor suppressor WT1 gene product. Mol Endocrinol 8: 595 – 602PubMedCrossRefGoogle Scholar
  11. Drummond IA, Madden SL, Rowher-Nutter P, Bell GL, Sukhatme VP, Rauscher III FJ (1992) Repression of the insulin-like growth factor-11 gene by the Wilms’ tumor suppressor WT1. Science 257: 674 – 678PubMedCrossRefGoogle Scholar
  12. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher III FJ, Sukhatme VP (1994) DNA recognition by variants of the Wilms’ tumor suppressor, WTl. Mol Cell Biol 14: 3800 – 3809PubMedGoogle Scholar
  13. Gashler AL, Bonthron DT, Madden SL, Rauscher III FJ, Collins T, Sukhatme VP (1992) Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms’ tumor suppressor WT1. Proc Natl Acad Sci USA 89: 10984 – 10988PubMedCrossRefGoogle Scholar
  14. Gerald WL, Miller HK, Battifora H, Miettinen M, Silva EG, Rosai J (1991) Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 15: 499 – 513PubMedCrossRefGoogle Scholar
  15. Goodyer P, Dehbi M, Torban E, Bruening W, Pelletier J (1995) Repression of the retinoic acid receptor alpha gene by the Wilms’ tumor suppressor gene product, wt1. Oncogene 10: 1125 – 1129PubMedGoogle Scholar
  16. Haber DA, Housman DE (1992) The genetics of Wilms’ tumor. Adv Cancer Res 59: 41 – 68PubMedCrossRefGoogle Scholar
  17. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990) An internal deletion within in 11p13 zinc finger gene contributes to the development of Wilms’ tumor. Cell 61: 1257 – 1269PubMedCrossRefGoogle Scholar
  18. Haber DA, Sohn RL, Buckler A J, Pelletier J, Call KM, Housman DE (1991) Alternative splicing and genomic structure of the Wilms’ tumor gene WTl. Proc Natl Acad Sci USA 88: 9618 – 9622PubMedCrossRefGoogle Scholar
  19. Haber DA, Timmer HT, Pelletier J, Sharp PA, Housman DE (1992) A dominant mutation in Wilms’ tumor gene WT1 cooperatives with the viral oncogene EIA in transformation of primary kidney cells. Proc Natl Acad Sci USA 89: 6010 – 6014PubMedCrossRefGoogle Scholar
  20. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN (1995) A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10: 1229 – 1234PubMedGoogle Scholar
  21. Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishikira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F, Fujinaga K (1996) Fusion of an ETS-family gene, E1AF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chrom Cancer 15: 115 – 121PubMedCrossRefGoogle Scholar
  22. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74: 679 – 691PubMedCrossRefGoogle Scholar
  23. Labelle Y, Zucman J, Stenman G, Kindblom L-G, Knight J, Turc-Carel C, Dockhorn-Dworniczak B, Mandahl N, Desmaze C, Peter M, Aurias A, Delattre O, Thomas G (1995) Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Gen 4: 2219 – 2226PubMedCrossRefGoogle Scholar
  24. Ladanyi M, Gerald W (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54: 2837 – 2840PubMedGoogle Scholar
  25. Larsson SH, Charlieu J-P, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing Cell 81: 391 – 401PubMedGoogle Scholar
  26. Madden SL, Rauscher III FJ (1993) Positive and negative regulation of transcription and cell growth mediated by the EGR family of zinc finger gene products. In: Zinc-finger proteins in oncogenesis: DNA-binding and gene regulation. Ann NY Acad Sci 684: 75 – 84Google Scholar
  27. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher III FJ (1991) Transcriptional repression mediated by the WT1 Wilms’ tumor gene product. Science 253: 1550 – 1553PubMedCrossRefGoogle Scholar
  28. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher III FJ, Hill DE, Haber DA (1993) Interaction between the p53 and Wilms’ tumor (WT1) gene products: physical association and functional cooperation. Proc Natl Acad Sci USA 90: 5100 – 5104PubMedCrossRefGoogle Scholar
  29. Ordonez NG, Zirkin R, Bloom RE (1989) Malignant small-cell epithelial tumor of the peritoneum co-expressing mesenchymal-type intermediate filaments. Am J Surg Pathol 13: 413^421Google Scholar
  30. Ordonez NG, El-Naggar AK, Ro JY, Silva EG, Mackay B (1993) Intra-abdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol 24: 850 – 865PubMedCrossRefGoogle Scholar
  31. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman RL, Haber DA, Housman D (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67: 437 – 447PubMedCrossRefGoogle Scholar
  32. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastie N (1990) The candidate Wilms’ tumor gene is involved in genitourinary development. Nature 346: 194 – 197PubMedCrossRefGoogle Scholar
  33. Rabbits TH, Forster A, Larson R, Nathan P (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet 4: 175 – 180CrossRefGoogle Scholar
  34. Rauscher III FJ, Morris JF, Tournay OE, Cook DM, Curran T (1990) Binding of the Wilms’ tumor locus zinc finger protein in the EGR-1 consensus sequence. Science 250: 1259 – 1262PubMedCrossRefGoogle Scholar
  35. Rauscher III FJ, Benjamin LE, Fredericks WJ, Morris JF (1994) Novel oncogenic mutations in the WT1 Wilms’ tumor suppressor gene. A recurrent t(ll;22) fuses the Ewings’ Sarcoma gene, EWS1 to WT1 in desmoplastic small round cell tumor. Gold Spring Harbor Symposium on Quantitative Biology. Cold Spring Harbor 59: 137 – 146Google Scholar
  36. Rodriguez E, Sreekantaiah C, Gerald W, Reuter VE, Motzer RJ, Chaganti RSK (1993) A recurring translocation t(11;22)(p12;q11.2) characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cytogenet 69: 17 – 21PubMedCrossRefGoogle Scholar
  37. Ryan G, Steele-Perkins V, Morris JM, Rauscher III FJ, Dressler GR (1995) Repression of Pax-2 by WT1 during normal kidney development. Development 129: 867 – 875Google Scholar
  38. Sawyer JR, Tryka AF, Lewis JM (1992) A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor. Am J Surg Pathol 16: 411 – 416PubMedCrossRefGoogle Scholar
  39. Saxen L (1987) Organogenesis of the kidney. Cambridge University Press, CambridgeCrossRefGoogle Scholar
  40. Sharma PM, Bowman M, Madden SL, Rauscher III FJ, Sukumar S (1994) RNA editing in the Wilms’ tumor susceptibility gene, WT1. Genes Dev 8: 720 – 731PubMedCrossRefGoogle Scholar
  41. Shen WP, Towne B, Zadeh TM (1992) Cytogenetic abnormalities in an intra-abdominal desmoplastic small cell tumor. Cancer Genet Cytogenet 64: 189 – 191PubMedCrossRefGoogle Scholar
  42. Sorenson PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT (1994) A second Ewing’s sarcoma translocation t(21;22) fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet 6: 146 – 151CrossRefGoogle Scholar
  43. Sukhatme VP (1990) Early transcriptional events in cell growth: the Egr family. J Am Soc Nephrol 1: 859 – 866PubMedGoogle Scholar
  44. Urano F, Umezawa A, Hong W, Kikuchi H, Hata J-i (1996) A novel chimera gene between EWSand EIA-F, encoding the adenovirus EIA enhancer-binding protein, in extraosseous Ewing’s Sarcoma. 219: 608 – 61Google Scholar
  45. Wang ZY, Madden SL, Deuel TF, Rauscher III FJ (1992) The human platelet-derived growth factor A-chain (PDGF-A) gene is a target for repression by the WT1 Wilms’ tumor protein. J Biol Chem 267: 21999 – 22002PubMedGoogle Scholar
  46. Werner H, Rauscher III FJ, Sukhatme VP, Drummond IA, Roberts Jr CT, LeRoith D (1994) Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences upstream and downstream of the IGF-I-R transcription start site. J Biol Chem 269: 12577 – 12582PubMedGoogle Scholar
  47. Zucman J, Delattre O, Desmaze C, Epstein A, Stenman G, Speleman F, Fletchers CDM, Aurias A, Thomas G (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet 4: 341 – 345PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • F. J. RauscherIII
    • 1
  1. 1.The Wistar InstitutePhiladelphiaUSA

Personalised recommendations